Patients with type 2 diabetes mellitus present similar immunological response to COVID-19 BNT162b2 mRNA vaccine to healthy subjects: a prospective cohort study

被引:5
作者
Paschou, Stavroula A. [1 ]
Karalis, Vangelis [2 ]
Psaltopoulou, Theodora [3 ]
Charitaki, Ioanna [3 ]
Sklirou, Aimilia D. [4 ]
Iconomidou, Vassiliki A. [4 ]
Vasileiou, Vasiliki [5 ]
Kassi, Georgia N. [5 ]
Vryonidou, Andromachi [6 ,7 ]
Kokkinos, Alexander [8 ]
Tentolouris, Nicholas [8 ]
Hatziaggelaki, Erifili [9 ]
Trougakos, Ioannis P. [4 ]
Terpos, Evangelos [3 ]
Dimopoulos, Meletios Athanasios [3 ]
机构
[1] Natl & Kapodistrian Univ Athens, Sch Med, Alexandra Hosp, Endocrine Unit & Diabet Ctr,Dept Clin Therapeut, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Sch Hlth Sci, Fac Pharm, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, 80 Vasilisis Sophias Ave, Athens 11528, Greece
[4] Natl & Kapodistrian Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens, Greece
[5] Alexandra Hosp, Dept Endocrinol, Athens, Greece
[6] Hellen Red Cross Hosp, Dept Endocrinol, Athens, Greece
[7] Hellen Red Cross Hosp, Diabet Ctr, Athens, Greece
[8] Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Dept Propaedeut Internal Med 1, Diabet Ctr, Athens, Greece
[9] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Internal Med 2, Diabet Ctr, Athens, Greece
来源
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM | 2023年 / 22卷 / 01期
关键词
Type; 2; diabetes; Diabetes mellitus; Hyperglycemia; Vaccination; COVID-19; Immune response; SARS-CoV-2; ENDOCRINE;
D O I
10.1007/s42000-022-00405-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To compare the kinetics of neutralizing antibodies (N Alpha bs) against SARS-CoV-2 after vaccination with the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech) between patients with T2DM and healthy controls. Methods NAb levels after the BNT162b2 mRNA vaccine were compared between 50 patients with non-insulin treated T2DM and 50 age-, gender-, and BMI-matched healthy controls up to 3 months after the second dose. The median age of both groups was 70 years. Results On day 1, mean NAbs of the control and T2DM groups were 14.64% (standard error, SE = 2.30) and 14.04% (SE = 2.14), respectively (p value = 0.926). Three weeks later, the mean NAb values were 39.98% (SE = 3.53) in the control group and 40.97% (SE = 3.99) in participants with T2DM (p value = 0.698). One month after the second vaccination, mean NAb values increased to 87.13% (SE = 2.94) in the control group and 89.00% (SE = 2.18) in the T2DM group. Three months after the second vaccine dose, the mean inhibitory titers decreased to 83.49% (SE = 3.82) (control group) and 76.36% (SE = 3.33) (T2DM group). On all occasions, no significant difference was found between the two groups (all p values > 0.05). Conclusions Patients with T2DM present similar immunological response to COVID-19 BNT162b2 mRNA vaccine to that of healthy subjects.
引用
收藏
页码:5 / 11
页数:7
相关论文
共 24 条
[11]   Gender differences in COVID-19 [J].
Paschou, Stavroula A. ;
Psaltopoulou, Theodora ;
Halvatsiotis, Panagiotis ;
Raptis, Athanasios ;
V. Vlachopoulos, Charalambos ;
Dimopoulos, Meletios-Athanasios .
MATURITAS, 2022, 161 :72-73
[12]   Patients With Autoimmune Thyroiditis Present Similar Immunological Response to COVID-19 BNT162b2 mRNA Vaccine With Healthy Subjects, While Vaccination May Affect Thyroid Function: A Clinical Study [J].
Paschou, Stavroula A. ;
Karalis, Vangelis ;
Psaltopoulou, Theodora ;
Vasileiou, Vasiliki ;
Charitaki, Ioanna ;
Bagratuni, Tina ;
Ktena, Vassiliki ;
Papandroulaki, Fotini ;
Gumeni, Sentiljana ;
Kassi, Georgia N. ;
Trougakos, Ioannis P. ;
Terpos, Evangelos ;
Dimopoulos, Meletios A. .
FRONTIERS IN ENDOCRINOLOGY, 2022, 13
[13]  
Patel Eshan U, 2020, medRxiv, DOI [10.1128/JCM.02257-20, 10.1101/2020.08.31.20184788]
[14]  
Pellini R, 2021, OBESITY MAY HAMPER S, V2021, DOI DOI 10.1101/2021.02.24.21251664
[15]   Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine [J].
Polack, Fernando P. ;
Thomas, Stephen J. ;
Kitchin, Nicholas ;
Absalon, Judith ;
Gurtman, Alejandra ;
Lockhart, Stephen ;
Perez, John L. ;
Perez Marc, Gonzalo ;
Moreira, Edson D. ;
Zerbini, Cristiano ;
Bailey, Ruth ;
Swanson, Kena A. ;
Roychoudhury, Satrajit ;
Koury, Kenneth ;
Li, Ping ;
Kalina, Warren V. ;
Cooper, David ;
Frenck, Robert W., Jr. ;
Hammitt, Laura L. ;
Tureci, Ozlem ;
Nell, Haylene ;
Schaefer, Axel ;
Unal, Serhat ;
Tresnan, Dina B. ;
Mather, Susan ;
Dormitzer, Philip R. ;
Sahin, Ugur ;
Jansen, Kathrin U. ;
Gruber, William C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27) :2603-2615
[16]   COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology [J].
Puig-Domingo, M. ;
Marazuela, M. ;
Yildiz, B. O. ;
Giustina, A. .
ENDOCRINE, 2021, 72 (02) :301-316
[17]   COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology [J].
Puig-Domingo, M. ;
Marazuela, M. ;
Giustina, A. .
ENDOCRINE, 2020, 68 (01) :2-5
[18]   Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutralization assay [J].
Rus, Katarina Resman ;
Korva, Misa ;
Knap, Natasa ;
Zupanc, Tatjana Avsic ;
Poljak, Mario .
JOURNAL OF CLINICAL VIROLOGY, 2021, 139
[19]   Humoral immune response to COVID-19 vaccination in diabetes is age-dependent but independent of type of diabetes and glycaemic control: The prospective COVAC-DM cohort study [J].
Sourij, Caren ;
Tripolt, Norbert J. ;
Aziz, Faisal ;
Aberer, Felix ;
Forstner, Patrick ;
Obermayer, Anna M. ;
Kojzar, Harald ;
Kleinhappl, Barbara ;
Pferschy, Peter N. ;
Mader, Julia K. ;
Cvirn, Gerhard ;
Goswami, Nandu ;
Wachsmuth, Nadine ;
Eckstein, Max L. ;
Mueller, Alexander ;
Abbas, Farah ;
Lenz, Jacqueline ;
Steinberger, Michaela ;
Knoll, Lisa ;
Krause, Robert ;
Stradner, Martin ;
Schlenke, Peter ;
Sareban, Nazanin ;
Prietl, Barbara ;
Kaser, Susanne ;
Moser, Othmar ;
Steinmetz, Ivo ;
Sourij, Harald .
DIABETES OBESITY & METABOLISM, 2022, 24 (05) :849-858
[20]   Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy Individuals [J].
Terpos, Evangelos ;
Karalis, Vangelis ;
Ntanasis-Stathopoulos, Ioannis ;
Gavriatopoulou, Maria ;
Gumeni, Sentiljana ;
Malandrakis, Panagiotis ;
Papanagnou, Eleni-Dimitra ;
Kastritis, Efstathios ;
Trougakos, Ioannis P. ;
Dimopoulos, Meletios A. .
LIFE-BASEL, 2021, 11 (10)